cGMP-GLP NMR capabilities highlighted at 2018 AAPS
Alameda, CA – Ron Najafi, Ph.D., CEO and founder of Emery Pharma, and Neeku Mahdavian, Business Development Manager of Emery Pharma, will be attending the 2018 American Association of Pharmaceutical Scientists (AAPS) Conference, held on November 4-7, 2018 in Washington, D.C. The team at Emery Pharma will be showcasing its cGMP-GLP NMR capabilities and will be available to respond to questions and participate in one-on-one meetings with all conference attendees.
Event: 2018 AAPS Annual Meeting: PharmSci 360
Location: Walter E. Washington Convention Center, Washington, D.C.
Date: November 4-7th, 2018
Place: Booth #320
We look forward to seeing you there!
About Emery Pharma
“Helping Our Clients Save Lives and Save the Environment”
Located in Alameda, CA, the heart of the San Francisco Bay Area, Emery Pharma is an FDA registered, DEA licensed, and cGMP-GLP compliant full-service contract research and development laboratory. Combining the best intellectual resources with sophisticated instrumentation, the team specializes in analytical chemistry, microbiology, and cell biology services. Our mission is to support biotech and pharmaceutical companies aiming to save lives and save the environment.
The team at Emery Pharma has vast experience in method development and validation, characterization and isolation of impurities, stability studies, and release testing. We have proprietary and robust microbiological assays aimed to support projects related to novel antimicrobial, anti-biofilm, and antibiotic development. Our team also has extensive litigation support experience, including patent litigation, intellectual property, and product liability cases. Contact us and let us know how we can help advance your project.
Stay connected with Emery Pharma:
Contact us at: +1-510-899-8814 or 1-888-98-EMERY
For more information contact:
Neeku Mahdavian, +1-510-899-8825